John Baldoni's most recent trade in MiNK Therapeutics Inc was a trade of 6,878 Common stock done at an average price of $2.1 . Disclosure was reported to the exchange on March 1, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
MiNK Therapeutics Inc | John Baldoni | Director | Grant, award, or other acquisition of securities at price $ 2.09 per share. | 01 Mar 2023 | 6,878 | 23,360 | - | 2.1 | 14,375 | Common stock |
MiNK Therapeutics Inc | John Baldoni | Director | Grant, award, or other acquisition of securities at price $ 2.61 per share. | 01 Dec 2022 | 5,508 | 16,482 | - | 2.6 | 14,376 | Common stock |
MiNK Therapeutics Inc | John Baldoni | Director | Grant, award, or other acquisition of securities at price $ 2.62 per share. | 15 Sep 2022 | 10,974 | 10,974 | - | 2.6 | 28,752 | Common stock |
MiNK Therapeutics Inc | John Baldoni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) |